Biotechnology leadership, strategy and operations consulting for therapeutics and diagnostic effort.

RADx is the Rapid Acceleration of Diagnostics COVID-19 Response Program at The National Institutes of Health

SBIR/STTR Non-HIV Diagnostics, Food Safety, Sterilization/Disinfection and Bioremediation Study Section

Leading the worlds premier synthetic biology diagnostics company. Making food safer using the worlds fastest food pathogen test. Revolutionizing data visibility and converting information into action!

Sample6 Technologies is the developer of the world’s first “enrichment-free” diagnostics platform powered by synthetic biology. It is backed by top tier venture capitalists including Canaan Partners, Cultivian Sandbox Ventures, Flybridge Capital Partners, Chevron Tech Ventures, The Kraft Group, Founder Collective and Boston University. The company is based in Boston, MA. Learn more at www.Sample6.com

Co-founder, COO and President of a cutting edge molecular diagnostics startup aiming to transform and secure the global food chain. (f.k.a. Novophage)

Co-founder and President of Sample6, f.k.a. Novophage. Using combination therapeutic approaches to combat antibiotic-resistant bacterial infections. Competed successfully in business plan competition, winning $100K: BU (1), HBS (2), MIT (2), Purdue (1), UC Berkeley (2), UC SB (2), UN Lincoln (2), UT Austin Moot Corp (1), and USF (1).

Member of the Scientific Advisory Board focusing on bacteriophages and synthetic biology

Biotech Start is a nonprofit, free resource for collating, sharing, and developing innovative ideas for turning scientific discoveries into world changing biotechnology startups.More Biotech Startups. Faster!

The Leadership Excellence Accelerator Program (LEAP) provides Fellows with mentorship, practical skills and a sustaining network to help them guide a socially responsible future for synthetic biology.Catalyzing a community of emerging leaders in synthetic biology to create bold new visions and strategies for developing biotechnology in the public interest.

Sourced, evaluated, and presented biotech-focused new venture opportunities. Conceptualized, and generated novel IP to support new ventures.

Co-Founder of the Healthcare Entrepreneurship Program (HCEP), now HealthTECC at BU School of Management.The Healthcare Consulting and Entrepreneurship Program (HCEP), now known as Health TECC, was established at Boston University in 2006. HCEP’s mission is to initiate and support entrepreneurial business development in health care, focusing on the incubation and start-up phase. Market areas that HCEP focuses on include medical devices, biopharma, health services, and other types of health care technology.HCEP members are an interdisciplinary group with MBA students, bioengineers, PhD students in life sciences, and medical students who have consulting experience with early-stage companies in the diagnostics, medical devices, and therapeutics spaces. In advising start-up companies, HCEP also draws on University experts and its broad network of outside advisors and contacts. Boston University’s initiatives devoted to entrepreneurial business development include the Office of Technology Development (venture capital and technology transfer), several business incubators (Photonics Center, BioSquare), the Fraunhofer USA Center, and the Entrepreneurial Management Institute (EMI) at the School of Management.

Research scientist in a major biochemical / biophysical laboratory at MIT's Department of Biology.

Study on outsourcing feasibility of the chemical engineering and chemical plant for a large pharmaceutical company in Germany. Succesful pitch led to accquisition of project.